A

Aviad Tsherniak

Broad Institute

ORCID: 0000-0002-3797-1877

Publishes on CRISPR and Genetic Engineering, Protein Degradation and Inhibitors, Cancer-related gene regulation. 221 papers and 25.8k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

🌱#4 Emerging Leader in Advanced biosensing and bioanalysis techniques 🌱#4 Emerging Leader in CRISPR and Genetic Engineering

221Publications

25.8kTotal Citations

#4in Advanced biosensing and bioanalysis techniques

First publication: 2007First senior author: 2016

CRISPR and Genetic Engineering Protein Degradation and Inhibitors Cancer-related gene regulation Cancer Genomics and Diagnostics Cancer Mechanisms and Therapy

Top publicationsby citations

Genetic and transcriptional evolution alters cancer cell line drug response

Uri Ben‐David, Todd R. Golub, Benjamin A. Siranosian et al.|Nature|2018

Cited by 943

Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

Steven M. Corsello, Todd R. Golub, Rohith T. Nagari et al.|Nature Cancer|2020

Cited by 880

Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting

Andrew J. Aguirre, William C. Hahn, Robin M. Meyers et al.|Cancer Discovery|2016

Cited by 632

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

Roel G.W. Verhaak, Matthew Meyerson, Pablo Tamayo et al.|Journal of Clinical Investigation|2012

Cited by 591

Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity

Gabriela Sarti Kinker, Itay Tirosh, Alissa Greenwald et al.|Nature Genetics|2020

Cited by 465